|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/24 | |
| A61K 31/155 | |||
| A61K 31/70 | |||
| A61K 31/7034 | |||
| A61K 31/7042 | |||
| A61K 31/7004 | |||
| A61K 31/403 | |||
| A61K 45/06 | |||
| A61P 3/00 | |||
| A61P 3/04 | |||
| A61P 3/06 | |||
| A61P 3/10 | |||
| A61P 5/50 | |||
| A61P 9/10 | |||
| A61P 9/12 | |||
| A61P 13/12 | |||
| A61P 17/02 | |||
| A61P 25/00 | |||
| A61P 27/02 | |||
| A61P 27/12 | |||
| A61P 43/00 | |||
| A61K 9/20 |
| (11) | Number of the document | 3315124 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17206106.1 |
| Date of filing the European patent application | 2010-11-12 | |
| (97) | Date of publication of the European application | 2018-05-02 |
| (45) | Date of publication and mention of the grant of the patent | 2021-01-06 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 261087 P | 2009-11-13 | US |
| (72) |
ABEBE, Admassu, US
MARTIN, Kyle, US
PATEL, Jatin M., US
DESAI, Divyakant, US
TIMMINS, Peter, US
|
| (73) |
AstraZeneca UK Limited,
1 Francis Crick Avenue, Cambridge Biomedical Campus Cambridge CB2 0AA,
GB
Astrazeneca AB, 151 85 Södertälje, SE |
| (54) | BILAYER TABLET FORMULATIONS |
| BILAYER TABLET FORMULATIONS |